+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Physiological bicarbonate buffers: stabilisation and use as dissolution media for modified release systems

Physiological bicarbonate buffers: stabilisation and use as dissolution media for modified release systems

International Journal of Pharmaceutics 382(1-2): 56-60

Bicarbonate media are reflective of the ionic composition and buffer capacity of small intestinal luminal fluids. Here we investigate methods to stabilise bicarbonate buffers which can be readily applied to USP-II dissolution apparatus. The in vitro drug release behaviour of three enteric coated mesalazine (mesalamine) products is investigated. Asacol 400 mg and Asacol 800 mg (Asacol HD) and the new generation, high dose (1200 mg) delayed and sustained release formulation, Mezavant (Lialda), are compared in pH 7.4 Krebs bicarbonate and phosphate buffers. Bicarbonate stabilisation was achieved by: continuous sparging of the medium with 5% CO(2)(g), application of a layer of liquid paraffin above the medium, or a specially designed in-house seal device that prevents CO(2)(g) loss. Each of the products displayed a delayed onset of drug release in physiological bicarbonate media compared to phosphate buffer. Moreover, Mezavant displayed a zero-order, sustained release profile in phosphate buffer; in bicarbonate media, however, this slow drug release was no longer apparent and a profile similar to that of Asacol 400 mg was observed. These similar release patterns of Asacol 400 mg and Mezavant displayed in bicarbonate media are in agreement with their pharmacokinetic profiles in humans. Bicarbonate media provide a better prediction of the in vivo behaviour of the mesalazine preparations investigated.

(PDF emailed within 0-6 h: $19.90)

Accession: 055001424

Download citation: RISBibTeXText

PMID: 19666093

DOI: 10.1016/j.ijpharm.2009.08.003

Related references

Predicting the gastrointestinal behaviour of modified-release products: utility of a novel dynamic dissolution test apparatus involving the use of bicarbonate buffers. International Journal of Pharmaceutics 475(1-2): 585-591, 2015

Toward an in vivo dissolution methodology: a comparison of phosphate and bicarbonate buffers. Molecular Pharmaceutics 6(1): 29-39, 2009

In vitro dissolution of oral modified-release tablets and capsules in ethanolic media. International Journal of Pharmaceutics 398(1-2): 93-96, 2011

Effect of dissolution media and additives on the drug release from cubic phase delivery systems. Journal Of Controlled Release. 46(3): 215-222, 1997

Lactation and physiological responses to the ruminal buffers, sodium bicarbonate and trona. Journal of Dairy Science 69(Suppl. 1): 155, 1986

Production and physiological responses of lactating dairy cows fed bicarbonate buffers. Canadian Journal of Animal Science 66(4): 1203, 1986

Lactation and physiological responses to ruminal buffers sodium bicarbonate and trona. Journal of Dairy Science 69(SUPPL 1): 155, 1986

The course of the reaction in physiological buffers with special reference to the CO2-bicarbonate system Abstract. Skand Arch Physiol 49: 104-105, 1926

Use of apparatus IV in characterizing the dissolution of poorly soluble drugs from modified release, microcrystalline cellulose pellet systems. Pharmaceutical Research (New York) 10(10 SUPPL ): S37, 1993

Dissolution of theophylline from film-coated slow release mini-tablets in various dissolution media. Journal of Pharmacy and Pharmacology 41(6): 369-372, 1989

Investigation of the Dissolution Profile of Gliclazide Modified-Release Tablets Using Different Apparatuses and Dissolution Conditions. Aaps Pharmscitech (): -, 2016

Interaction between fed gastric media (Ensure PlusĀ®) and different hypromellose based caffeine controlled release tablets: comparison and mechanistic study of caffeine release in fed and fasted media versus water using the USP dissolution apparatus 3. International Journal of Pharmaceutics 461(1-2): 419-426, 2015

Crystal dissolution-controlled release systems. II. Metronidazole release from semicrystalline poly(vinyl alcohol) systems. Journal of Biomedical Materials Research 36(1): 125-130, 1997

Simulation of physiological ph time profile in in vitro dissolution study relationship between dissolution rate and bioavailability of controlled release dosage form. Drug Development & Industrial Pharmacy 14(4): 537-544, 1988